Stock listing

NASDAQ:APGE Apogee Therapeutics, Inc. Stock

Home listing (NASDAQ) of Apogee Therapeutics, Inc.

Follow Apogee Therapeutics, Inc. into a list and get an email when it puts out news.

Apogee Therapeutics, Inc. logo
Ticker
NASDAQ:APGE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Apogee Therapeutics (NASDAQ:APGE) Q1 2026 Earnings Call

    Mon, Mar 23, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

Jun 22, 2026

Apogee Therapeutics to Participate in Upcoming June Conferences

May 28, 2026

Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis

May 27, 2026

Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart

May 27, 2026

Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026

May 26, 2026

Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results

May 11, 2026

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Mar 26, 2026

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

Mar 24, 2026

Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering

Mar 23, 2026

Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis

Mar 23, 2026

All Apogee Therapeutics, Inc. news

Decks

Apogee Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 71 in all · newest Jun 22, 2026 · oldest 2023
Calls
1 call with a replay · 1 with a transcript · latest Mar 23, 2026
Decks
11 decks · latest Jun 22, 2026

Where Apogee Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:APGE · Home listing · This pageNASDAQUnited StatesUSD
BOATS:APGEBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Apogee Therapeutics, Inc.